MNPR
Monopar TherapeuticsCompany with tickers: MNPR
CIK
1645469
CUSIP
61023L207
Shares Outstanding
6,699,062
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $0 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $5,225,253 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $3,487,247 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-5,225,253 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-3,893,050 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-0.46 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | — |